These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 10394017)

  • 1. Amphotericin B colloidal dispersion. Pre-clinical review.
    Working PK
    Chemotherapy; 1999 Jun; 45 Suppl 1():15-26. PubMed ID: 10394017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amphotericin B colloidal dispersion: an improved antifungal therapy.
    Guo LS
    Adv Drug Deliv Rev; 2001 Apr; 47(2-3):149-63. PubMed ID: 11311990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.
    Brogden RN; Goa KL; Coukell AJ
    Drugs; 1998 Sep; 56(3):365-83. PubMed ID: 9777313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses.
    Oppenheim BA; Herbrecht R; Kusne S
    Clin Infect Dis; 1995 Nov; 21(5):1145-53. PubMed ID: 8589134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative toxicities and pharmacokinetics of intrathecal lipid (amphotericin B colloidal dispersion) and conventional deoxycholate formulations of amphotericin B in rabbits.
    Clemons KV; Sobel RA; Williams PL; Stevens DA
    Antimicrob Agents Chemother; 2001 Feb; 45(2):612-5. PubMed ID: 11158765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy of amphotericin B colloidal dispersion against infections caused by Candida spp.
    Dupont B
    Chemotherapy; 1999 Jun; 45 Suppl 1():27-33. PubMed ID: 10394018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amphotericin B colloidal dispersion.
    Patel R
    Expert Opin Pharmacother; 2000 Mar; 1(3):475-88. PubMed ID: 11249532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy of amphotericin B colloidal dispersion against infections caused by Aspergillus spp.
    Gurwith M
    Chemotherapy; 1999 Jun; 45 Suppl 1():34-8. PubMed ID: 10394019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compartmentalized intrapulmonary pharmacokinetics of amphotericin B and its lipid formulations.
    Groll AH; Lyman CA; Petraitis V; Petraitiene R; Armstrong D; Mickiene D; Alfaro RM; Schaufele RL; Sein T; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3418-23. PubMed ID: 17005824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of amphotericin B colloidal dispersion.
    Herbrecht R
    Eur J Clin Microbiol Infect Dis; 1997 Jan; 16(1):74-80. PubMed ID: 9063677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of amphotericin B colloidal dispersion (amphocil).
    Stevens DA
    J Infect; 1994 May; 28 Suppl 1():45-9. PubMed ID: 8077690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential treatment of deep fungal infections with amphotericin B deoxycholate and amphotericin B colloidal dispersion.
    Beović B; Lejko-Zupanc T; Pretnar J
    Eur J Clin Microbiol Infect Dis; 1997 Jul; 16(7):507-11. PubMed ID: 9272385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of amphotericin B colloidal dispersion in children.
    Sandler ES; Mustafa MM; Tkaczewski I; Graham ML; Morrison VA; Green M; Trigg M; Abboud M; Aquino VM; Gurwith M; Pietrelli L
    J Pediatr Hematol Oncol; 2000; 22(3):242-6. PubMed ID: 10864055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal sparing by amphotericin B colloidal dispersion: clinical experience in 572 patients.
    Gurwith M; Mamelok R; Pietrelli L; Du Mond C
    Chemotherapy; 1999 Jun; 45 Suppl 1():39-47. PubMed ID: 10394020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The population pharmacokinetics of amphotericin B colloidal dispersion in patients receiving bone marrow transplants.
    Amantea MA; Bowden RA; Forrest A; Working PK; Newman MS; Mamelok RD
    Chemotherapy; 1999 Jun; 45 Suppl 1():48-53. PubMed ID: 10394021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhinocerebral mucormycosis treated with amphotericin B colloidal dispersion in three patients.
    Moses AE; Rahav G; Barenholz Y; Elidan J; Azaz B; Gillis S; Brickman M; Polacheck I; Shapiro M
    Clin Infect Dis; 1998 Jun; 26(6):1430-3. PubMed ID: 9636875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia.
    White MH; Bowden RA; Sandler ES; Graham ML; Noskin GA; Wingard JR; Goldman M; van Burik JA; McCabe A; Lin JS; Gurwith M; Miller CB
    Clin Infect Dis; 1998 Aug; 27(2):296-302. PubMed ID: 9709879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats.
    Fielding RM; Smith PC; Wang LH; Porter J; Guo LS
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1208-13. PubMed ID: 1929263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of amphotericin B colloidal dispersion. An overview.
    Herbrecht R; Letscher V; Andres E; Cavalier A
    Chemotherapy; 1999 Jun; 45 Suppl 1():67-76. PubMed ID: 10394023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative tissue distribution and elimination of amphotericin B colloidal dispersion (Amphocil) and Fungizone after repeated dosing in rats.
    Wang LH; Fielding RM; Smith PC; Guo LS
    Pharm Res; 1995 Feb; 12(2):275-83. PubMed ID: 7784345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.